# Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

> **NCT04997096** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 30 (estimated)

## Conditions studied

- Ovarian Cancer
- Ovarian Carcinoma
- Ovarian Cancer Stage IV
- Ovarian Cancer Stage III
- Ovarian Cancer Stage 3
- Endometrial Cancer
- Endometrial Cancer Stage

## Interventions

- **OTHER:** Exercise
- **OTHER:** Attention Control

## Key facts

- **NCT ID:** NCT04997096
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-02
- **Primary completion:** 2029-02-01
- **Final completion:** 2029-04-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04997096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04997096, "Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04997096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*